GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (LSE:ONT) » Definitions » ROE % Adjusted to Book Value

Oxford Nanopore Technologies (LSE:ONT) ROE % Adjusted to Book Value : -9.45% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies ROE % Adjusted to Book Value?

Oxford Nanopore Technologies's ROE % for the quarter that ended in Dec. 2023 was -26.27%. Oxford Nanopore Technologies's PB Ratio for the quarter that ended in Dec. 2023 was 2.78. Oxford Nanopore Technologies's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -9.45%.


Oxford Nanopore Technologies ROE % Adjusted to Book Value Historical Data

The historical data trend for Oxford Nanopore Technologies's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies ROE % Adjusted to Book Value Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - -4.63 -4.45 -8.31

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.72 -2.70 -5.85 -7.64 -9.45

Competitive Comparison of Oxford Nanopore Technologies's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Oxford Nanopore Technologies's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Nanopore Technologies's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's ROE % Adjusted to Book Value falls into.



Oxford Nanopore Technologies ROE % Adjusted to Book Value Calculation

Oxford Nanopore Technologies's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-23.11% / 2.78
=-8.31%

Oxford Nanopore Technologies's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-26.27% / 2.78
=-9.45%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Nanopore Technologies ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Nanopore Technologies (LSE:ONT) Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX44DQ
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The Group is primarily involved in researching, developing, manufacturing, and commercializing the world's only commercial nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables our customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science.

Oxford Nanopore Technologies (LSE:ONT) Headlines

No Headlines